FIELD: organic synthesis.
SUBSTANCE: invention relates to a method of the preparation of 3,5-difluoro-benzylamide (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid (compound S-9), which is an inhibitor of MetAP-2. The method of preparing S-9 is characterized by the following: 2-oxo-1-(1-(phenylsulfonyl)-1H-indol-5-yl)pyrrolidine-3-carboxylic acid (compound 5) is reacted with 3,5-difluorobenzylamine with producing 1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-2-oxopyrrolidine-3-carboxamide (compound 12). Then, in a key step, compound 12 is enantioselectively oxidized using the asymmetric oxidizing agent "Davis oxaziridine" to give (3S)-1-[1-(benzenesulfonyl)-1H-indol-5-yl]-N-[(3,5-difluorophenyl)methyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide (compound 13). The phenylsulfonyl group of compound 13 is then eliminated to give 3,5-difluorobenzylamide (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acidю
EFFECT: provision of a method of obtaining the target product with fewer synthesis steps.
8 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING (S)-3-HYDROXY-1-(1H-INDOL-5-YL)-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 3,5-DIFLUORO-BENZYLAMIDE | 2020 |
|
RU2826010C2 |
NEW 3-INDOLE SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION | 2016 |
|
RU2672252C1 |
(AZA)INDOLE-, BENZOTHIOPHENE- AND BENZOFURAN-3-SULPHONAMIDES | 2017 |
|
RU2767904C2 |
PYRIDINIL- AND PYRAZINYL(AZA)INDOLSULFONAMIDES | 2019 |
|
RU2799321C2 |
COMPOUNDS OF FORMULA (I) AND FORMULA (A), PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, USE AND METHOD OF OBTAINING COMPOUNDS OF FORMULA (I) | 2018 |
|
RU2822758C2 |
DERIVATIVES OF PYRIDINE AND APPLICATION THEREOF AGAINST MICROBACTERIA | 2015 |
|
RU2664587C1 |
NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
SPIRO COMPOUNDS AS ANTAGONISTS OF MELANOCORTIN 4 RECEPTORS AND THEIR USE | 2021 |
|
RU2813541C1 |
DERIVATIVES OF 2-PHENOXY AND 2-PHENYLSULPHONAMIDE WITH CCR3 ANTAGONISTIC ACTIVITY FOR TREATING ASTHMA AND OTHER INFLAMMATORY OR IMMUNOLOGICAL DISEASES | 2004 |
|
RU2380356C2 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
Authors
Dates
2024-02-09—Published
2020-06-30—Filed